GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Inhibikase Therapeutics

IKT 1.97 +3.14%

Close of 9 October 2026, in USD — never converted.

Inhibikase Therapeutics — daily IKT Delayed

Chart and prices are provided by TradingView. Global Banking & Finance Review publishes no price data on this page. Nothing here is investment advice. How we cover markets.

Other Health Care listings

Latest on Inhibikase Therapeutics

Frequently asked questions

What is Inhibikase Therapeutics's ticker?

Inhibikase Therapeutics trades as IKT on its US listing, under ISIN US45719W2052.

What was Inhibikase Therapeutics's last closing price?

1.97 on 9 October 2026. The figure is in USD and is never converted.

Does Global Banking & Finance Review publish price data for Inhibikase Therapeutics?

We publish the closing prices we record ourselves, in the currency the instrument trades in. Charts and live quotes come from TradingView. Nothing on this page is investment advice.